Intracellular Fas Ligand Expression Causes Fas-Mediated Apoptosis in Human Prostate Cancer Cells Resistant to Monoclonal Antibody-Induced Apoptosis

This publication has 35 references indexed in Scilit:

• Cancer statistics, 1999
  CA: A Cancer Journal for Clinicians, 1999
• Fas ligand is not only expressed in immune privileged human organs but is also coexpressed with Fas in various epithelial tissues.
  Molecular Pathology, 1997
• Cytometry in cell necrobiology: Analysis of apoptosis and accidental cell death (necrosis)
  Cytometry, 1997
• An Enhanced Green Fluorescent Protein Allows Sensitive Detection of Gene Transfer in Mammalian Cells
  Biochemical and Biophysical Research Communications, 1996
• FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex
  Cell, 1996
• Involvement of MACH, a Novel MORT1/FADD-Interacting Protease, in Fas/APO-1- and TNF Receptor–Induced Cell Death
  Cell, 1996
• Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover.
  The Journal of cell biology, 1996
• Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege
  Science, 1995
• A role for CD95 ligand in preventing graft rejection
  Nature, 1995
• Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
  Nature, 1992